Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsor Statesort icon
2010-12-24 InCCNM -I CIGB Registered
2008-09-19 Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba. FINLAY Registered
2010-12-27 Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III. CIM Registered
2008-07-29 A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers. FINLAY Registered
2008-07-29 Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age. FINLAY Registered
2010-12-17 Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I. CIM Registered
2008-07-29 A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET. FINLAY Registered
2008-07-29 A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine. FINLAY Registered
2009-02-26 CITOPROT-III CIGB Registered
2010-12-24 Application of CIGB-128 in keloid patients undergoing surgical exeresis. CIGB Registered
2010-12-24 CIGB-128 administration to patients with surgically-treated keloids. CIGB Registered
2010-12-27 Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed CIGB Registered
2008-09-18 Tisuacryl® in Dental Hyperesthesia BIOMAT Registered
2008-10-16 FASECU I CIGB Registered
2010-12-28 InCarbacel-II CIGB Registered
2009-02-11 Recombinant interferon alpha-2b in paranoid schizophrenia. CIGB Registered
2010-12-17 NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II CIM Registered
2010-12-17 99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II CIM Registered
2010-12-17 NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. CIM Registered
2010-12-17 Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors. CIM Registered